PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1460734
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1460734
Market Overview
In 2023, the biocatalyst market was valued at USD 607.6 million and is projected to grow at a CAGR of 6.3% from 2024 to 2030, reaching USD 925.2 million by 2030.
Biocatalysts sourced from biological origins offer an eco-friendly substitute for synthetic catalysts, commonly derived from petroleum, across various industrial sectors. They play a significant role in producing both specialty and commodity chemicals.
The advancement of cost-effective genetic engineering techniques has significantly contributed to their increased manufacturing. These bio-enzymes enable precise reactions, leading to desired outcomes with minimal waste and fewer by-products, bolstering their appeal in industrial processes.
Biocatalysts are progressively becoming functional in biotransformation procedures, and therefore, they have become significant nearly in all industries, mainly chemicals, and pharmaceuticals. The growth of lucrative and ecological chemoenzymatic processes strongly relies on the extensive accessibility and pertinency of enzymes with high performance, irrespective of ecological conditions.
Biocatalysis guarantees that compound molecules are made with high accuracy while meeting severe quality standards. This adhesive their cruciality in the pharmacological sector, where accurate quality and concentrations are important.
The most prominent industrial applications of biocatalysis are stereospecific compounds (also called chiral compounds) used for pharmaceuticals aromas and fragrances. Chiral hydroxyl moieties medium compounds exist in various APIs as well as they are used in the production of various chemicals for use in pharmaceuticals.
Key Insights
In 2023, hydrolases held 40% of the industry revenue, essential in diverse biological procedures such as lipases, amidases, and proteases.
Hydrolases feature prominently in permitted medications for conditions such as Alzheimer's, diabetes, and communicable diseases.
These enzymes are also used in detergent formulations to eliminate blood and protein stains, guaranteeing clean clothes.
In 2023, the food & beverages category had a 25% revenue share among biocatalyst applications.
Biocatalysts are vital enzymes in food processing and additive production.
Sectors such as brewing, bakery, dairy, meat, beverages, and sugar use bio-enzymes widely.
Biocatalysis is favored because of growing ecological awareness and sustainability requirements, providing advanced effectiveness and safety.
Its sustainability stems from working under mild conditions and decreasing energy use, waste, and by-products.
Constant innovation permits biocatalysis to evolve and fulfill diverse market requirements efficiently.
In 2023, microorganisms contributed USD 0.2 billion to the industry, and the category is projected to showcase significant growth.
Enzymes from microbial sources are lucrative, scalable for wholesale production, and have high enzyme content.
Microbe-based enzymes are strong, quicken reactions efficiently, produce diverse compounds, and provide cost benefits.
In 2023, the North American region arose as the largest revenue contributor to the worldwide biocatalyst industry and is projected to uphold a substantial development trajectory.
This development is mainly propelled by the strong pharmaceutical and food sectors dominant in the region, which cater as major industry drivers.
The United States and Europe comprise the two leading superpowers of the world pharmaceutical industry, with America capturing 49.1% of the market and Europe controlling 23.4% of the global turnover of pharmaceuticals in 2021.
Statics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveal the contribution of the United States and Europe was 64.4% and 16.2% respectively, newly drugs launched between 2016 and 2021.